U.S., Feb. 15 -- ClinicalTrials.gov registry received information related to the study (NCT06826742) titled 'Intravenous Methadone Versus Intrathecal Morphine for Analgesia Following Cesarean Delivery' on Feb. 10.
Brief Summary: The purpose of this study is to determine if there is a difference in opioid requirements at 0-48 hours after scheduled cesarean delivery in patients receiving 150 mcg intrathecal morphine compared to 0.2 mg/kg (maximum 20 mg) intravenous methadone.
Study Start Date: Feb., 2025
Study Type: INTERVENTIONAL
Condition:
Cesarean Delivery
Intervention:
DRUG: Intravenous line (IV) Methadone
Subjects will receive standardized spinal anesthesia without intrathecal morphine (intrathecal 1.6-2 mL 0.75% bupivacaine + de...